182 related articles for article (PubMed ID: 3260776)
1. Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells.
Kelm M; Feelisch M; Spahr R; Piper HM; Noack E; Schrader J
Biochem Biophys Res Commun; 1988 Jul; 154(1):236-44. PubMed ID: 3260776
[TBL] [Abstract][Full Text] [Related]
2. Release of the free nitric oxide radical (NO) and EDRF from endothelial cells.
Kelm M; Feelisch M; Schrader J
Z Kardiol; 1989; 78 Suppl 6():70-4. PubMed ID: 2618132
[TBL] [Abstract][Full Text] [Related]
3. Close correlation between cytoplasmic Ca++ levels and release of an endothelium-derived relaxing factor from cultured endothelial cells.
Korenaga R; Ando J; Ohtsuka A; Sakuma I; Yang W; Toyo-oka T; Kamiya A
Cell Struct Funct; 1993 Apr; 18(2):95-104. PubMed ID: 8364982
[TBL] [Abstract][Full Text] [Related]
4. Alkaline buffers release EDRF from bovine cultured aortic endothelial cells.
Mitchell JA; de Nucci G; Warner TD; Vane JR
Br J Pharmacol; 1991 Jun; 103(2):1295-302. PubMed ID: 1884092
[TBL] [Abstract][Full Text] [Related]
5. Differential control and calcium-dependence of production of endothelium-derived relaxing factor and prostacyclin by pig aortic endothelial cells.
White DG; Martin W
Br J Pharmacol; 1989 Jul; 97(3):683-90. PubMed ID: 2547481
[TBL] [Abstract][Full Text] [Related]
6. Effects of hypoxia and metabolic inhibitors on production of prostacyclin and endothelium-derived relaxing factor by pig aortic endothelial cells.
Richards JM; Gibson IF; Martin W
Br J Pharmacol; 1991 Jan; 102(1):203-9. PubMed ID: 1646057
[TBL] [Abstract][Full Text] [Related]
7. Endothelium-dependent relaxation is independent of arachidonic acid release.
Milner PG; Izzo NJ; Saye J; Loeb AL; Johns RA; Peach MJ
J Clin Invest; 1988 Jun; 81(6):1795-803. PubMed ID: 3133395
[TBL] [Abstract][Full Text] [Related]
8. [Release of endothelium-derived relaxing factor (EDRF) from cultured vascular endothelial cells depends on extra- and intracellular Ca2+ concentrations].
Korenaga R
Hokkaido Igaku Zasshi; 1993 Sep; 68(5):744-54. PubMed ID: 8225180
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
Palmer RM; Ferrige AG; Moncada S
Nature; 1987 Jun 11-17; 327(6122):524-6. PubMed ID: 3495737
[TBL] [Abstract][Full Text] [Related]
10. EDRF and nitric oxide production in cultured endothelial cells: direct inhibition by E. coli endotoxin.
Myers PR; Wright TF; Tanner MA; Adams HR
Am J Physiol; 1992 Mar; 262(3 Pt 2):H710-8. PubMed ID: 1558180
[TBL] [Abstract][Full Text] [Related]
11. Different patterns of release of endothelium-derived relaxing factor and prostacyclin.
Mitchell JA; de Nucci G; Warner TD; Vane JR
Br J Pharmacol; 1992 Feb; 105(2):485-9. PubMed ID: 1373103
[TBL] [Abstract][Full Text] [Related]
12. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1987 Nov; 92(3):639-46. PubMed ID: 3322462
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin and inositol 1,4,5-trisphosphate-stimulated calcium release from intracellular stores in cultured bovine endothelial cells.
Freay A; Johns A; Adams DJ; Ryan US; Van Breemen C
Pflugers Arch; 1989 Aug; 414(4):377-84. PubMed ID: 2798038
[TBL] [Abstract][Full Text] [Related]
14. Extracellular ATP and bradykinin increase cGMP in vascular endothelial cells via activation of PKC.
Castro AF; Amorena C; Müller A; Ottaviano G; Tellez-Iñon MT; Taquini AC
Am J Physiol; 1998 Jul; 275(1):C113-9. PubMed ID: 9688841
[TBL] [Abstract][Full Text] [Related]
15. Release of NO and EDRF from cultured bovine aortic endothelial cells.
Myers PR; Guerra R; Harrison DG
Am J Physiol; 1989 Apr; 256(4 Pt 2):H1030-7. PubMed ID: 2784944
[TBL] [Abstract][Full Text] [Related]
16. Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells.
Gryglewski RJ; Moncada S; Palmer RM
Br J Pharmacol; 1986 Apr; 87(4):685-94. PubMed ID: 3085757
[TBL] [Abstract][Full Text] [Related]
17. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
Shikano K; Berkowitz BA
J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
[TBL] [Abstract][Full Text] [Related]
18. Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells.
Lückhoff A; Pohl U; Mülsch A; Busse R
Br J Pharmacol; 1988 Sep; 95(1):189-96. PubMed ID: 3064851
[TBL] [Abstract][Full Text] [Related]
19. [Endothelial relaxation factor as a local modulator of arterial function. The possibility of stabilization].
Vedernikov IuP; Gräzer T; Osis IuG
Fiziol Zh SSSR Im I M Sechenova; 1988 Feb; 74(2):153-61. PubMed ID: 3259514
[TBL] [Abstract][Full Text] [Related]
20. Does halothane interfere with the release, action, or stability of endothelium-derived relaxing factor/nitric oxide?
Blaise G; To Q; Parent M; Lagarde B; Asenjo F; Sauvé R
Anesthesiology; 1994 Feb; 80(2):417-26. PubMed ID: 8311324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
